Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19179217.
- Also identified by DOI 10.1016/j.jacc.2008.09.054.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
High admission blood glucose levels after acute myocardial infarction are common and associated with an increased risk of death in patients with or without diabetes. Hyperglycemia is associated with altered myocardial blood flow and energetics and can lead to a pro-oxidative/proinflammatory state. The use of intensive insulin treatment has shown superior benefits in the treatment of hyperglycemia versus glucose-insulin-potassium infusion, particularly in critical care settings.
Medical subject headings
- Blood Glucose
- Critical Care
- Hyperglycemia
- Hypoglycemic Agents
- Insulin
- Myocardial Infarction